Profile data is unavailable for this security.
About the company
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
- Revenue in USD (TTM)136.74m
- Net income in USD-18.26m
- Incorporated1996
- Employees365.00
- LocationAvid Bioservices Inc14191 MYFORD ROADTUSTIN 92780United StatesUSA
- Phone+1 (714) 508-6100
- Fax+1 (714) 838-5817
- Websitehttps://avidbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nkarta Inc | 0.00 | -116.20m | 423.51m | 150.00 | -- | 0.894 | -- | -- | -2.35 | -2.35 | 0.00 | 6.72 | 0.00 | -- | -- | 0.00 | -22.45 | -32.39 | -23.55 | -34.05 | -- | -- | -- | -372,519.20 | -- | -- | 0.00 | -- | -- | -- | -3.22 | -- | 106.05 | -- |
| IGM Biosciences Inc | 2.11m | -236.92m | 429.69m | 216.00 | -- | 2.66 | -- | 204.13 | -4.31 | -4.31 | 0.0375 | 2.74 | 0.005 | -- | -- | 9,397.32 | -56.49 | -44.66 | -62.57 | -48.20 | -- | -- | -11,255.25 | -23,668.96 | -- | -- | 0.00 | -- | 99.25 | -- | -11.45 | -- | 73.48 | -- |
| Altimmune Inc | 410.00k | -92.77m | 433.21m | 59.00 | -- | 2.50 | -- | 1,056.62 | -1.59 | -1.59 | 0.007 | 2.44 | 0.0022 | -- | 1.47 | 6,949.15 | -49.42 | -39.62 | -53.14 | -42.58 | -- | -- | -22,626.10 | -1,811.89 | -- | -- | 0.00 | -- | 726.47 | -47.15 | -4.41 | -- | -45.92 | -- |
| Tourmaline Bio Inc | 0.00 | -32.94m | 434.96m | 44.00 | -- | 1.23 | -- | -- | -5.35 | -5.35 | 0.00 | 13.81 | 0.00 | -- | -- | 0.00 | -12.39 | -- | -12.75 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.99 | -- | -- | -- |
| Exscientia PLC (ADR) | 24.87m | -164.01m | 436.19m | 483.00 | -- | 1.52 | -- | 17.54 | -1.30 | -1.30 | 0.1968 | 3.32 | 0.0364 | -- | 34.98 | 51,484.14 | -24.02 | -- | -27.31 | -- | -34.40 | -- | -659.56 | -- | -- | -- | 0.0556 | -- | -26.24 | -- | -22.94 | -- | -- | -- |
| Tscan Therapeutics Inc | 14.81m | -96.80m | 444.05m | 161.00 | -- | 3.27 | -- | 29.98 | -1.28 | -1.28 | 0.1784 | 2.57 | 0.0715 | -- | -- | 96,181.82 | -46.72 | -- | -52.48 | -- | -- | -- | -653.50 | -- | -- | -- | 0.1974 | -- | 55.52 | -- | -34.73 | -- | -- | -- |
| Avid Bioservices Inc | 136.74m | -18.26m | 449.75m | 365.00 | -- | 2.50 | -- | 3.29 | -0.2888 | -0.2888 | 2.17 | 2.84 | 0.302 | 3.18 | 4.89 | 374,616.40 | -4.03 | 10.70 | -6.13 | 15.18 | 7.47 | 22.72 | -13.35 | 25.86 | 0.3097 | -4.47 | 0.4548 | 0.00 | 24.81 | 22.72 | -99.80 | -- | 82.98 | -- |
| Absci Corp | 5.35m | -109.19m | 450.07m | 155.00 | -- | 1.87 | -- | 84.17 | -1.17 | -1.17 | 0.0569 | 2.12 | 0.0187 | -- | 7.82 | 34,496.77 | -38.26 | -- | -42.14 | -- | -- | -- | -2,042.01 | -- | -- | -107.74 | 0.0298 | -- | -0.5046 | -- | -5.40 | -- | -- | -- |
| Alector Inc | 96.41m | -120.61m | 451.08m | 244.00 | -- | 2.52 | -- | 4.68 | -1.39 | -1.39 | 1.12 | 1.86 | 0.1393 | -- | -- | 395,106.60 | -17.43 | -20.00 | -21.55 | -23.81 | -- | -- | -125.11 | -124.07 | -- | -- | 0.00 | -- | -27.36 | 28.52 | 2.19 | -- | 4.79 | -- |
| Verve Therapeutics Inc | 16.05m | -196.83m | 455.09m | 255.00 | -- | 0.7792 | -- | 28.36 | -2.87 | -2.87 | 0.2309 | 6.96 | 0.0235 | -- | 4.48 | 62,937.25 | -28.80 | -- | -30.24 | -- | -- | -- | -1,226.43 | -- | -- | -- | 0.00 | -- | 505.77 | -- | -27.12 | -- | -- | -- |
| Compass Pathways PLC (ADR) | 0.00 | -129.44m | 455.42m | 186.00 | -- | 1.76 | -- | -- | -2.37 | -2.37 | 0.00 | 3.79 | 0.00 | -- | -- | 0.00 | -53.68 | -40.85 | -57.32 | -44.48 | -- | -- | -- | -- | -- | -43.34 | 0.1009 | -- | -- | -- | -29.46 | -- | -12.68 | -- |
| Adaptive Biotechnologies Corp | 174.50m | -215.06m | 461.26m | 709.00 | -- | 1.68 | -- | 2.64 | -1.48 | -1.48 | 1.20 | 1.87 | 0.2472 | 4.52 | 4.78 | 246,124.10 | -30.48 | -19.69 | -34.73 | -22.06 | 57.06 | 67.18 | -123.29 | -122.27 | 4.35 | -- | 0.3238 | -- | -8.11 | 25.06 | -12.52 | -- | 11.11 | -- |
| Voyager Therapeutics Inc | 119.04m | -3.04m | 462.89m | 162.00 | -- | 1.36 | 304.93 | 3.89 | -0.1812 | -0.1812 | 2.44 | 6.28 | 0.2954 | -- | 8.27 | 734,839.50 | -0.7554 | 0.6378 | -0.8534 | 0.8203 | -- | -- | -2.56 | 1.30 | -- | -- | 0.00 | 0.00 | 511.16 | 101.01 | 385.14 | -- | -5.43 | -- |
| Fulcrum Therapeutics Inc | 2.51m | -99.43m | 463.04m | 76.00 | -- | 2.17 | -- | 184.48 | -1.61 | -1.61 | 0.0406 | 3.44 | 0.0091 | -- | 2.14 | 33,026.32 | -35.91 | -50.55 | -37.62 | -55.91 | -- | -- | -3,961.20 | -1,189.10 | -- | -- | 0.00 | -- | -55.77 | -- | 11.41 | -- | -43.70 | -- |
| Lenz Therapeutics Inc | 0.00 | -117.37m | 473.41m | 6.00 | -- | 2.39 | -- | -- | -15.88 | -15.88 | 0.00 | 7.77 | 0.00 | -- | -- | 0.00 | -44.51 | -- | -47.51 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.35 | -- | -- | -- |
| SIGA Technologies Inc | 157.02m | 79.26m | 474.39m | 45.00 | 6.08 | 2.88 | 5.94 | 3.02 | 1.10 | 1.10 | 2.20 | 2.32 | 0.7354 | 0.3631 | 10.32 | 3,489,424.00 | 37.12 | 22.34 | 47.49 | 27.56 | 87.71 | 88.65 | 50.48 | 41.14 | 2.19 | -- | 0.00 | 29.51 | 26.31 | -21.75 | 100.76 | -30.57 | -26.67 | -- |
Data as of Jun 14 2024. Currency figures normalised to Avid Bioservices Inc's reporting currency: US Dollar USD
54.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 5.85m | 9.21% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 4.46m | 7.03% |
| Millennium Management LLCas of 31 Mar 2024 | 4.40m | 6.94% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 3.49m | 5.50% |
| Point72 Asset Management LPas of 25 Apr 2024 | 3.23m | 5.08% |
| AltraVue Capital LLCas of 31 Mar 2024 | 3.16m | 4.97% |
| 12 West Capital Management LPas of 31 Mar 2024 | 2.75m | 4.33% |
| RBC Global Asset Management (US), Inc.as of 31 Mar 2024 | 2.59m | 4.08% |
| Snyder Capital Management LPas of 31 Mar 2024 | 2.18m | 3.44% |
| Palisade Capital Management LPas of 31 Mar 2024 | 2.17m | 3.42% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
